NICE Cost-Effectiveness Appraisal of Cholinesterase Inhibitors Denis GetsiosKristen Migliaccio-WalleJaime J. Caro Current Opinion 28 November 2012 Pages: 997 - 1006
Recombinant Factor VIIa (Eptacog Alfa) Katherine A. Lyseng-WilliamsonGreg L. Plosker Adis Pharmacoeconomic Drug Evaluation 28 November 2012 Pages: 1007 - 1029
Atorvastatin Greg L. PloskerKatherine A. Lyseng-Williamson Adis Pharmacoeconomic Drug Evaluation 28 November 2012 Pages: 1031 - 1053
Economic Evidence at the Local Level Kees van GoolGisselle GallegoRobyn Ward Leading Article 28 November 2012 Pages: 1055 - 1062
Oral Antiplatelet Therapy in Secondary Prevention of Cardiovascular Events Bart HeegJoep DamenBen Van Hout Original Research Article 28 November 2012 Pages: 1063 - 1082